14th International Conference on Alzheimer’s Drug Discovery
September 9-10, 2013 | Jersey City, New Jersey
This annual conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientist in the field will present their current research, provide progress updates and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.
ADDF to Exhibit at the Society for Neuroscience Annual Meeting
November 9-13, 2013 l San Diego, CA
For more information on our scientific programs and funding opportunities, please visit the ADDF at booth during the Society for Neuroscience Annual Meeting.
8th Annual Drug Discovery for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs
Date and location TBA
Past 2013 Conferences
7th Annual Drug Discovery for Neurodegeneration Conference: An Intensive Course on Translating Research into Drugs
February 10-12, 2013 I San Francisco, California
7th Annual Drug Discovery for Neurodegeneration Conference course is designed to advance the development of new drugs for neurodegenerative diseases by educating scientists on the principles and practice of drug discovery, including topics such as high throughput screening, lead optimization, preclinical proof-of-concept, and IND enabling and regulator issues. The program will focus on Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis and Multiple Sclerosis.
Translating Natural Products into Drugs for Alzheimer’s Disease and Neurodegenerative Disease
May 6, 2013 | New York City, New York
Historically, natural products have been a highly successful source for the development of new drugs. Alzheimer’s and other neurodegenerative diseases are fraught with challenging drug targets that may benefit from the novel chemistries present in natural products. In addition, technological advances may present new opportunities for drug discovery based on natural product leads. This conference will present an overview of drug discovery from natural products, including novel approaches and technologies, and promising Alzheimer’s drug discovery programs that originated from natural products.
For a complete list of the ADDF’s past scientific conferences, please visit our conference program archives here.
For more information about an upcoming conference, please contact Sara Classen at 212-901-8009 or firstname.lastname@example.org.